全文获取类型
收费全文 | 954篇 |
免费 | 97篇 |
国内免费 | 41篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 30篇 |
妇产科学 | 5篇 |
基础医学 | 224篇 |
口腔科学 | 21篇 |
临床医学 | 72篇 |
内科学 | 206篇 |
皮肤病学 | 10篇 |
神经病学 | 59篇 |
特种医学 | 15篇 |
外科学 | 61篇 |
综合类 | 133篇 |
预防医学 | 16篇 |
眼科学 | 21篇 |
药学 | 127篇 |
中国医学 | 43篇 |
肿瘤学 | 48篇 |
出版年
2024年 | 1篇 |
2023年 | 10篇 |
2022年 | 34篇 |
2021年 | 41篇 |
2020年 | 39篇 |
2019年 | 36篇 |
2018年 | 37篇 |
2017年 | 31篇 |
2016年 | 33篇 |
2015年 | 47篇 |
2014年 | 52篇 |
2013年 | 74篇 |
2012年 | 50篇 |
2011年 | 43篇 |
2010年 | 42篇 |
2009年 | 50篇 |
2008年 | 46篇 |
2007年 | 34篇 |
2006年 | 34篇 |
2005年 | 40篇 |
2004年 | 39篇 |
2003年 | 36篇 |
2002年 | 24篇 |
2001年 | 23篇 |
2000年 | 27篇 |
1999年 | 22篇 |
1998年 | 15篇 |
1997年 | 16篇 |
1996年 | 13篇 |
1995年 | 12篇 |
1994年 | 11篇 |
1993年 | 6篇 |
1992年 | 10篇 |
1991年 | 5篇 |
1990年 | 5篇 |
1989年 | 5篇 |
1988年 | 6篇 |
1987年 | 1篇 |
1986年 | 8篇 |
1985年 | 10篇 |
1984年 | 10篇 |
1983年 | 2篇 |
1982年 | 6篇 |
1981年 | 1篇 |
1980年 | 5篇 |
排序方式: 共有1092条查询结果,搜索用时 0 毫秒
1.
目的建立单抗N糖分析方法的系统适用性对照品,并设定相应的系统适用性要求。方法利用液质联用(LC-MS)仪对N糖系统适用性对照品进行N糖型的表征鉴别,并对对照品进行稳定性评价。结合方法特点和验证数据,对系统适用性要求进行设定。结果建立的系统适用性对照品具有良好的稳定性,其糖型涵盖了单抗主要的N糖型种类。针对3种药典拟收录的单抗N糖分析方法,设定了以下系统适用性要求,包括:图谱与典型图谱相似、G1F(1,6)和G1F(1,3)的分离度应满足具体要求、G0F%应在规定的范围内、G0F保留时间的RSD应≤4%。结论建立了单抗N糖系统适用性对照品,可配合3种2020年版《中国药典》拟收录的N糖分析方法使用。 相似文献
2.
Dr. W. Wörner A. Preissner N. Rietbrock 《European journal of clinical pharmacology》1992,43(1):97-100
Summary Sera from 17 patients with Type I diabetes and 19 healthy volunteers have been examined to evaluate whether the kinetics of the binding of drugs to Site II of serum albumin is altered in diabetes. Stopped-flow measurements showed that the association velocity and the affinity constants of the fluorescent marker dansylsarcosine were significantly lower in diabetics (160 s–1 and 2.0 × 105 l·mol–1) than in non-diabetics (196s–1 and 4.0 × 105 l·mol–1). The dissociation velocity was not different [20.3 s–1 vs. 19.4 s–1]. Although patients with a reduced albumin concentration were excluded the diabetics had significantly lower concentrations than the healthy volunteers. There was a significant correlation between decreased glycosylation of albumin and increased association velocity. The dissociation velocity constants were correlated with the molar concentration ratio of free fatty acids/human serum albumin. Thus, the extent of glycosylation and the amount of fatty acids bound per mole albumin can both affect the kinetics of drug binding to Site II. The lower affinity in patients with Type I diabetes is due to the increased in the glycoalbumin concentration. 相似文献
3.
糖尿病肾脏胶原非酶糖化与氨基胍阿斯匹林的治疗作用 总被引:1,自引:0,他引:1
本实验系统观察了STZ所致糖尿病鼠在1、3、6个月后肾脏组织胶原发生非酶糖化的情况,及氨基胍、阿斯匹林对肾脏胶原非酶糖化的阻断作用。结果表明:各病程糖尿病动物肾组织的胶原含量和非酶糖化早期产物(5-HMF)及胶原相联荧光值均明显高于正常对照。氨基胍能够减弱糖尿病动物肾组织胶原含量的增加和荧光产物的生成,但对5-HMF含量无影响。阿斯匹林未显示出对胶原非酶糖化的影响。 相似文献
4.
Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study. 总被引:2,自引:0,他引:2
Andreas Fusshoeller Marcus Plail Bernd Grabensee Joerg Plum 《Nephrology, dialysis, transplantation》2004,19(8):2101-2106
BACKGROUND: In chronic ambulatory peritoneal dialysis, bicarbonate-buffered fluids, with their neutral pH and less advanced glycosylation end-products (AGE) and glucose degradation products (GDP), have better biocompatibility than conventional peritoneal dialysis (PD) solutions. That difference may be more beneficial in automated peritoneal dialysis (APD), due to its more frequent exchanges and longer contact times with fresh dialysate. We performed a prospective, randomized study in APD patients to compare the biocompatibility of conventional and bicarbonate/lactate-buffered PD fluids. METHODS: We randomized 14 APD patients to have APD with either conventional or bicarbonate/lactate-based fluids. After 6 months, both groups changed to the other solution. The overall observation period was 12 months. After 1 and 5 months and again after 7 and 11 months, phagocytotic and respiratory burst capacities of effluent peritoneal macrophages were determined. Plasma interleukin (IL)-6 and C-reactive protein (CRP) as well as effluent IL-6, CRP, transforming growth factor (TGF)-beta 1, AGE and CA125 concentrations were measured. Inflow pain was quantified using a patient questionnaire. RESULTS: Respiratory burst capacity remained unchanged and phagocytotic activity increased significantly during APD (P<0.001) with the bicarbonate/lactate fluid. Effluent IL-6 release was significantly lower than with the lactate fluid (P<0.05). While in the effluent TGF-beta 1 was unaffected, AGE concentration was lower after bicarbonate/lactate treatment (P<0.05). Effluent CA125 concentration, an indicator of mesothelial cell integrity, was higher (P<0.05) in neutral effluents. Finally, patients' inflow pain diminished (P = 0.05) when using the neutral fluid. CONCLUSIONS: The use of a neutral PD fluid in APD improved patients' inflow pain as well as biocompatibility parameters reflecting enhanced phagocytotic activity of peritoneal macrophages, reduced constitutive inflammatory stimulation (IL-6), reduced AGE accumulation in the peritoneal cavity and better preservation of the mesothelial cell integrity. From the biocompatibility point of view, a neutral fluid with low GDP content can be recommended as the primary choice for APD. 相似文献
5.
Kuroda Y Nakata M Hirose S Shirai T Iwamoto M Izui S Kojima N Mizuochi T 《Pathology international》2001,51(12):909-915
MRL-lpr/lpr (MRL/lpr) mice spontaneously develop arthritis by an increase in the incidence of agalactosylated oligosaccharides in serum IgG, similar to rheumatoid arthritis patients. However, whether this association has a pathogenic significance is still unknown. In this study, we analyzed the oligosaccharide structure of serum IgG in various MRL mice with or without arthritis, to clarify the relationship between the oligosaccharide abnormality and the development of arthritis. The level of agalactosylation in serum IgG was comparable in both arthritis-free MRL/lpr and MRL-+/+ (MRL/+) mice at 6 weeks of age. In contrast, the incidence of IgG lacking galactose markedly increased in MRL/lpr mice at 6 months of age (the age at which arthritis occurred), compared with that from age-matched MRL/+ mice without arthritis. However, the proportion of agalactosylated IgG increased similarly in anti-CD4 monoclonal antibody-treated MRL/lpr mice at 6 months of age, despite the absence of the development of arthritis, because of depletion of CD4+ T cells. These results suggest that the abnormality in IgG galactosylation of MRL/lpr mice developed in an age-dependent manner, but it did so independently of CD4+ T cell-dependent B-cell activation and is not a consequence of the development of arthritis. 相似文献
6.
Congenital Disorder of Glycosylation (CDG) type Ic is caused by mutations in ALG6. This gene encodes an alpha1,3 glucosyltransferase used for synthesis of the lipid linked oligosaccharide (LLO) precursor of the protein N-glycosylation pathway. CDG-Ic patients have moderate to severe psychomotor retardation, seizures, hypotonia, strabismus, and feeding difficulties. We previously identified a typical patient with a heterozygous point mutation, c.391T>C (p.Tyr131His) in ALG6. Using complementation analysis of ALG6-deficient yeast, we show that this alteration is as severe as the most common disease-causing mutation, c998C>T (p. Ala333Val), which occurs in over half of all known CDG-Ic patients. The frequency of c.391T>C (p.Tyr131His) in the US population, is 0.0214, suggesting that homozygotes would occur at a rate of& tilde;1:2,200. We identified one patient with typical CDG-Ic symptoms and a homozygous p.Tyr131His alteration in ALG6. However, in contrast to most CDG patients, her LLO and plasma transferrin glycosylation appeared normal. Thus, it is unclear whether c.391T>C causes CDG-Ic or contributes to the symptoms. Genotyping additional patients with CDG-like symptoms will be required to resolve this issue. 相似文献
7.
先天性糖基化病 (congenitaldisordersofglycosyla tion,CDG) ,旧称为糖类缺陷性糖蛋白综合征 (carbo hydrate-deficientglycoproteinsyndromes,CDGS) ,是一类由于聚糖的合成和结合到其他复合体 (蛋白质和脂质 )过程的缺陷引起的常染色体隐性遗传病[1,2 ] 。绝大多数CDG患者有多种系统病变且均有不同程度的精神发育迟缓。迄今发现的CDG主要是由于人体内蛋白N -糖基化途径缺陷引起的 ,不同酶的缺陷产生不同的CDG类型。最新的命名系统将脂联寡… 相似文献
8.
Summary Lens crystallins undergo non-enzymatic glycosylation with aging and diabetes mellitus. It is not known, however, whether all crystallins are subject to the same extent of glycosylation. Human diabetic lenses ( 80 years of age) were dissected into cortex and nucleus, then fractionated into various crystallins with gel chromatography (Sephacryl S-200, Sephdex G-75 or Bio Gel A-1 5m). The glycosylated crystallins were then separated from the nonglycosylated crystallins by affinity chromatography on Glyco Gel B boronic acid. The percentage of glycosylated crystallin was about 20–30%, and did not differ much among most crystallins, although -crystallin has significantly less (p < 0.01) glycosylated protein. The extent of glycosylation in the glycosylated crystallins, however, was found to be greater in the high molecular weight crystallins. The extent of glycosylation in -crystallins is approximately two to four times that observed in - or -crystallin. The extent of glycosylation appears to depend not only on the lysine content, which does not vary much among the crystallins, but also on the accessibility of the surface areas where lysine residues are located. This accessibility depends on the protein conformation and appears to correlate with protein unfolding. 相似文献
9.
10.
糖尿病大鼠视网膜微血管的重建及某些药物对其的影响 总被引:1,自引:0,他引:1
目的:研究糖尿病大鼠视网膜微血管的重建。方法:用链脲佐菌素(STZ)诱导SD大鼠建立糖尿病动物模型,运用视网膜消化铺片和图像分析方法观测糖尿病大鼠视网膜微血管的重建,及非酶糖化抑制剂和活血化瘀中药对其重建的影响。结果:在8周时毛细血管宽度即有显著性变化(P〈0.05),非酶糖化抑制剂和活血化瘀中药治疗组在8~12周后与糖尿病组有显著性差异(P〈0.05)。结论:(1)糖尿病促进了视网膜微血管的形态 相似文献